List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 334 studies with search of: "Cetuximab"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)
Conditions: Colorectal Cancer;   Liver Metastases
Interventions: Drug: Cetuximab;   Procedure: Liver resection;   Drug: Cetuximab and FOLFIRI;   Drug: Cetuximab and FOLFOX
2 Recruiting Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer
Conditions: Head and Neck;   Squamous Cell Cancer
Interventions: Biological: cetuximab;   Biological: cetuximab
3 Active, not recruiting Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Cetuximab;   Drug: Cetuximab and Pemetrexed
4 Recruiting Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients
Condition: Pancreatic Cancer
Interventions: Drug: Cetuximab;   Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Capecitabine;   Radiation: Radiotherapy
5 Recruiting Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: Cetuximab
6 Completed Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Cetuximab;   Drug: Pemetrexed;   Procedure: radiation therapy
7 Recruiting Study of IMC-A12, Alone or in Combination With Cetuximab, in Patients With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck
Condition: Head and Neck Cancer
Interventions: Biological: IMC-A12;   Biological: IMC-A12 + cetuximab
8 Active, not recruiting Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
Condition: Androgen-Independent Prostate Cancer
Interventions: Drug: Erbitux (cetuximab) and Novantrone (mitoxantrone);   Drug: Novantrone (mitoxantrone)
9 Recruiting Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC
Condition: Colorectal Cancer
Interventions: Drug: Irinotecan;   Drug: Capecitabine;   Drug: Cetuximab;   Drug: Oxaliplatin
10 Active, not recruiting Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer
Condition: Cancer
Interventions: Drug: Docetaxel;   Drug: Cisplatin;   Drug: Cetuximab;   Procedure: Radiation Therapy
11 Completed Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Cetuximab
12 Recruiting Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Abraxane;   Drug: Cetuximab;   Drug: Cetuximab;   Drug: Cisplatin;   Drug: 5-FU;   Radiation: Radiation (Post induction);   Drug: Cisplatin;   Drug: Cetuximab
13 Recruiting Erlotinib in Combination With Cetuximab
Condition: Advanced Cancers
Interventions: Drug: Erlotinib;   Drug: Cetuximab
14 Active, not recruiting Cetuximab and Carbo for ER/PR/HER2 Negative BC
Condition: Breast Cancer
Interventions: Drug: Carboplatin;   Drug: Cetuximab
15 Recruiting A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma
Interventions: Drug: Cetuximab;   Drug: Bevacizumab
16 Active, not recruiting FLOX in Combination With Cetuximab in First-Line Treatment of Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: FLOX (5-fluorouracil/folinic acid/oxaliplatin);   Drug: FLOX (5-fluorouracil/folinic acid/oxaliplatin) and Cetuximab;   Drug: FLOX (5-fluorouracil and folinic acid and oxaliplatin) intermittently and maintenance cetuximab
17 Not yet recruiting Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver
Conditions: Colon Cancer;   Colorectal Cancer
Interventions: Drug: SIR-spheres Agent Administration;   Drug: Cetuximab;   Drug: Irinotecan
18 Active, not recruiting Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.
Condition: Metastatic Colorectal Cancer
Interventions: Drug: UFOX + Cetuximab;   Drug: FOLFOX4 + Cetuximab
19 Active, not recruiting Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer
Condition: Rectal Cancer
Intervention: Drug: cetuximab, capecitabine
20 Not yet recruiting Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Cetuximab;   Drug: Cetuximab

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services